-
-
-
-
-
-
-
RedHill licenses Talicia to Middle East partner for $1.8M deal
-
-
-
-
-
-
-
RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Reports Positive New Data with Opaganib for Nuclear Radiation Injury
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces License Agreement with Gaelan Medical for Talicia in UAE
-
-
-
-
-
-
-
Redhill Biopharma (REDIF) Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034
-
68,946 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


